Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 50Lymphoid 34CNS 20Genitourinary 12Gastrointestinal 10Other hematologic neoplasm 4Gynecologic 4Other 3Head & Neck 2Dermatologic 2Thoracic 1Sarcoma 1Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Melanoma 1656Skin Neoplasms 355Lymphoma, T-Cell, Cutaneous 322Carcinoma, Basal Cell 241Mycosis Fungoides 227Sezary Syndrome 209Breast Neoplasms 196Leukemia, Lymphocytic, Chronic, B-Cell 193Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 187Precursor Cell Lymphoblastic Leukemia-Lymphoma 183Lymphoma, Large B-Cell, Diffuse 183Lymphoma, B-Cell, Marginal Zone 182Lymphoma, Mantle-Cell 181Hodgkin Disease 175Lymphoma 174Burkitt Lymphoma 173Uveal Melanoma 170Lymphoma, Large-Cell, Immunoblastic 168Multiple Myeloma 159Keratosis, Actinic 146Neoplasms 142Leukemia, Myeloid, Acute 134Neoplasm Metastasis 125Lymphoma, Large-Cell, Anaplastic 125Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 123Lung Neoplasms 120Immunoblastic Lymphadenopathy 115Leukemia, Myeloid, Accelerated Phase 113Leukemia, Myeloid, Chronic-Phase 112

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Cognitive Dysfunction × Dermatologic × Clear all
NCT07510061 2026-04-03

ICARUS

University of Thessaly

Phase NA Recruiting
80 enrolled
Dermatologic

Hyperthermia, Skin Neoplasms, Heat Stress Disorders, Cognitive Dysfunction

NCT04565769 2024-12-06

Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint Inhibitors

Aarhus University Hospital

Active not recruiting
100 enrolled
Dermatologic

Anxiety Disorders, Depression, Fatigue, Inflammation, Melanoma, Illness Behavior, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡